Key result
Significant venous obstruction in the subclavian vein was detected in 5.5% of patients with single-polyurethane-lead pacemakers, with no patients being symptomatic.
Why the study?
What is the incidence of significant venous thrombosis detected by transcutaneous ultrasound in patients with single-polyurethane-lead permanent pacemakers?
Population
109 consecutive patients with single-polyurethane-lead permanent pacemakers
Design
Cross-sectional
Authors
Loading...
Asymptomatic subclavian obstruction warrants no routine screening in single-lead pacemaker patients; leaves open longitudinal risks and lead-material effects.
Observational (n=109)
What is the incidence of significant venous thrombosis detected by transcutaneous ultrasound in patients with single-polyurethane-lead permanent pacemakers?
Significant asymptomatic venous obstruction occurs in approximately 5.5% of patients with single-polyurethane-lead pacemakers, with no clear association with traditional thrombogenic risk factors.
Lin et al. (1998) conducted an observational in Single-polyurethane-lead permanent pacemaker (n=109). Single-polyurethane-lead permanent pacemaker was evaluated on Significant venous obstruction in the subclavian vein. Significant venous obstruction in the subclavian vein was detected in 5.5% of patients with single-polyurethane-lead pacemakers, with no patients being symptomatic.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: